Aarti Drugs Ltd Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Consolidate Quarterly Results

Jun'26

Mar'26

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Net Sales

702.78

720.30

601.71

652.79

590.51

676.76

556.60

Other Operating Income

0.00

Total Operating income

702.78

720.30

601.71

652.79

590.51

676.76

556.60

Raw Material Cost

469.35

427.19

334.52

385.06

357.25

373.78

368.69

Purchase of Finished goods

21.38

33.32

22.51

30.64

28.61

23.13

14.11

(Increase) / Decrease In Stocks

-63.13

-10.09

29.61

-7.41

-12.47

38.64

-32.51

Employee Cost

36.51

32.28

33.16

33.07

30.80

31.35

27.76

Power Cost

0.00

Manufacturing Expenses

0.00

Selling and Distribution Expenses

0.00

Other Expenses

140.47

141.80

126.88

127.15

112.24

116.53

116.82

Total Expenditure (Excl Depreciation)

604.58

624.50

546.68

568.51

516.43

583.43

494.87

Operating Profit (PBDIT) excl Other Income

98.20

95.80

55.03

84.28

74.08

93.33

61.73

Other Income

0.81

0.76

1.23

0.09

0.31

1.87

11.90

Operating Profit (PBDIT)

99.01

96.56

56.26

84.37

74.39

95.20

73.63

Interest

9.22

8.16

9.29

7.70

8.56

9.16

9.07

Exceptional Items

-2.09

0.00

Gross Profit (PBDT)

87.70

88.40

46.97

76.67

65.83

86.04

64.56

Depreciation

18.46

18.04

17.95

16.26

14.72

14.88

13.80

Profit Before Tax

69.24

70.36

29.02

60.41

51.11

71.16

50.76

Tax

19.11

15.10

-11.53

15.25

-2.86

8.39

13.67

Provisions and contingencies

0.00

Profit After Tax

50.13

55.26

40.55

45.16

53.97

62.77

37.09

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

50.13

55.26

40.55

45.16

53.97

62.77

37.09

Share in Profit of Associates

0.00

Minority Interest

-0.04

0.07

0.01

-0.12

0.06

-0.09

0.04

Other related items

0.00

Consolidated Net Profit

50.17

55.19

40.54

45.28

53.91

62.86

37.05

Equity Capital

91.27

Face Value

10.0

Reserves

0.00

Earnings per share (EPS)

5.5

6.05

4.44

4.96

5.91

6.89

4.06

Diluted Earnings per share

5.49

6.05

4.44

4.95

5.91

6.88

4.06

Operating Profit Margin (Excl OI)

13.97%

13.3%

9.15%

12.91%

12.55%

13.79%

11.09%

Gross Profit Margin

12.48%

12.27%

7.81%

11.74%

11.15%

12.71%

11.6%

PAT Margin

7.13%

7.67%

6.74%

6.92%

9.14%

9.28%

6.66%

Public Share Holdings (%)

0.0%

Pledged Promotor Holding (%)

0.0%

Quarterly Analysis Highlights - QoQ

Net Sales

QoQ Growth in quarter ended Jun 2026 is -2.43% vs 19.71% in Mar 2026

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2026 is -9.10% vs 36.14% in Mar 2026

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2026 is 2.51% vs 74.09% in Mar 2026

Interest

QoQ Growth in quarter ended Jun 2026 is 12.99% vs -12.16% in Mar 2026

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

Compare Quarterly Results Of Aarti Drugs With

Select Peers

Figures in Cr

Consolidate Quarterly Results

Change(INR)

Change(%)

Net Sales

702.78

570.13

132.65

23.27%

Other Operating Income

0.00

Total Operating income

702.78

570.13

132.65

23.27%

Raw Material Cost

469.35

328.38

140.97

42.93%

Purchase of Finished goods

21.38

9.64

11.74

121.78%

(Increase) / Decrease In Stocks

-63.13

-19.32

-43.81

-226.76%

Employee Cost

36.51

62.44

-25.93

-41.53%

Power Cost

0.00

12.81

-12.81

-100.00%

Manufacturing Expenses

0.00

Selling and Distribution Expenses

0.00

58.96

-58.96

-100.00%

Other Expenses

140.47

34.68

105.79

305.05%

Total Expenditure (Excl Depreciation)

604.58

487.59

116.99

23.99%

Operating Profit (PBDIT) excl Other Income

98.20

82.54

15.66

18.97%

Other Income

0.81

5.18

-4.37

-84.36%

Operating Profit (PBDIT)

99.01

87.72

11.29

12.87%

Interest

9.22

4.84

4.38

90.50%

Exceptional Items

-2.09

0.00

-2.09

Gross Profit (PBDT)

87.70

82.88

4.82

5.82%

Depreciation

18.46

8.35

10.11

121.08%

Profit Before Tax

69.24

74.53

-5.29

-7.10%

Tax

19.11

18.18

0.93

5.12%

Provisions and contingencies

0.00

Profit After Tax

50.13

56.35

-6.22

-11.04%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

50.13

56.35

-6.22

-11.04%

Share in Profit of Associates

0.00

Minority Interest

-0.04

-0.05

0.01

20.00%

Other related items

0.00

Consolidated Net Profit

50.17

56.40

-6.23

-11.05%

Equity Capital

91.27

109.58

-18.31

-16.71%

Face Value

10.00

2.00

0.00

Reserves

0.00

Earnings per share (EPS)

5.50

1.03

4.47

433.98%

Diluted Earnings per share

5.49

1.03

4.46

433.01%

Operating Profit Margin (Excl OI)

13.97%

14.48%

0.00

-0.51%

Gross Profit Margin

12.48%

14.54%

0.00

-2.06%

PAT Margin

7.13%

9.88%

0.00

-2.75%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 702.78 Cr

in Jun 2026

Figures in Cr

QoQ Growth in quarter ended Jun 2026 is -2.43% vs 19.71% in Mar 2026

YoY Growth in quarter ended Jun 2026 is 19.01% vs 6.33% in Jun 2025

Quarterly - Consolidate Net Profit

Consolidate Net Profit 50.17 Cr

in Jun 2026

Figures in Cr

QoQ Growth in quarter ended Jun 2026 is -9.10% vs 36.14% in Mar 2026

YoY Growth in quarter ended Jun 2026 is -6.94% vs 62.18% in Jun 2025

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 98.20 Cr

in Jun 2026

Figures in Cr

QoQ Growth in quarter ended Jun 2026 is 2.51% vs 74.09% in Mar 2026

YoY Growth in quarter ended Jun 2026 is 32.56% vs 14.04% in Jun 2025

Quarterly - Interest

Interest 9.22 Cr

in Jun 2026

Figures in Cr

QoQ Growth in quarter ended Jun 2026 is 12.99% vs -12.16% in Mar 2026

YoY Growth in quarter ended Jun 2026 is 7.71% vs -1.72% in Jun 2025

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 13.97%

in Jun 2026

Figures in %

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

YoY Growth in quarter ended Jun 2026 has improved from Jun 2025